These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2178480)

  • 21. Endogenous angiotensin II levels and the mechanism of action of angiotensin-converting enzyme inhibitors and angiotensin receptor type 1 antagonists.
    Campbell DJ
    Clin Exp Pharmacol Physiol Suppl; 1996; 3():S125-31. PubMed ID: 8993851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin type 1 receptor mediates chronic ethanol consumption-induced hypertension and vascular oxidative stress.
    Passaglia P; Ceron CS; Mecawi AS; Antunes-Rodrigues J; Coelho EB; Tirapelli CR
    Vascul Pharmacol; 2015 Nov; 74():49-59. PubMed ID: 25872164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system.
    Hollenberg NK; Fisher ND; Price DA
    Hypertension; 1998 Sep; 32(3):387-92. PubMed ID: 9740600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vasopressin does not mediate the inhibition of ethanol drinking by the renin-angiotensin system.
    Ross AD; Perlanski E; Grupp LA
    Pharmacol Biochem Behav; 1990 Aug; 36(4):761-5. PubMed ID: 2217503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of combined administration of ACE inhibitor and angiotensin II receptor antagonist are prevented by a high NaCl intake.
    Griffiths CD; Morgan TO; Delbridge LM
    J Hypertens; 2001 Nov; 19(11):2087-95. PubMed ID: 11677376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
    Lantelme P; Lo M; Luttenauer L; Sassard J
    Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacodynamic effects of C-domain-specific ACE inhibitors on the renin-angiotensin system in myocardial infarcted rats.
    Sharp S; Poglitsch M; Zilla P; Davies NH; Sturrock ED
    J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1149-58. PubMed ID: 25757657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactive hyperreninemia is a major determinant of plasma angiotensin II during ACE inhibition.
    Mooser V; Nussberger J; Juillerat L; Burnier M; Waeber B; Bidiville J; Pauly N; Brunner HR
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):276-82. PubMed ID: 1689424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of the systemic and brain renin-angiotensin systems in the control of drinking and the central mediation of pressor responses.
    Robinson MM; McLennan GP; Thunhorst RL; Johnson AK
    Brain Res; 1999 Sep; 842(1):55-61. PubMed ID: 10526095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma and tissue concentrations of proangiotensin-12 in rats treated with inhibitors of the renin-angiotensin system.
    Nagata S; Kato J; Kuwasako K; Asami M; Kitamura K
    Hypertens Res; 2012 Feb; 35(2):234-8. PubMed ID: 21993212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
    Hollenberg NK
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of an angiotensin-converting-enzyme inhibitor on the plasma concentration of cytokines and vasoactive molecules in patients with coronary heart disease and hypertension].
    Khadartsev AA; Logatkina AV; Terekhov IV; Bondar SS; Bondar NV
    Ter Arkh; 2017; 89(12):97-102. PubMed ID: 29411767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats.
    Ménard J; Campbell DJ; Azizi M; Gonzales MF
    Circulation; 1997 Nov; 96(9):3072-8. PubMed ID: 9386177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity.
    Waeber B; Nussberger J; Juillerat L; Brunner HR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 4():S53-9. PubMed ID: 2483430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition.
    Hingorani AD; Jia H; Stevens PA; Hopper R; Dickerson JE; Brown MJ
    J Hypertens; 1995 Dec; 13(12 Pt 2):1602-9. PubMed ID: 8903618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.